Clozyl is an antimicrobial medicine used for the effective treatment of infections caused by anaerobic bacteria and susceptible protozoa. It works by disrupting the DNA structure of microorganisms, thereby inhibiting their growth and eliminating infection-causing pathogens. Clozyl is widely indicated for gastrointestinal infections, amoebiasis, giardiasis, trichomoniasis, bacterial vaginosis, and various anaerobic infections involving the abdomen, oral cavity, skin, and pelvic region. It is also used in the prevention and management of post-operative anaerobic infections. With its proven antimicrobial efficacy and broad therapeutic application, Clozyl plays an important role in infection control and supportive antimicrobial therapy in both adult and pediatric clinical practice.